A nationwide prospective randomized trial for diagnosing developmental disorders demonstrates genome sequencing outperforms standard of care
Year: 2026
Type: article
Study design: Clinical Trial
Abstract: BACKGROUND: Exome (ES) or genome (GS) sequencing are recommended as first- or second-tier molecular tests for patients with developmental disorders (DD), but the clinical utility of GS continues to be debated. METHODS: This prospective randomized trial involving all Belgian human genetics centers compared the standard of care (SoC) - combining ES and chromosomal microarray analysis or shallow GS - with GS for 567 individuals with unexplained DD. The study was retrospectively registered. RESULTS: The diagnostic yield of GS was 39.8% (113/284) vs. 30% for SoC (85/283) (p = 0.015), mainly due to an increased detection of single nucleotide variants and indels (+ 8.7%). GS also enabled the detection of three non-coding (potential) pathogenic variants. Across both study arms, the diagnostic yield was higher for females (45.5%, 97/213) compared to males (28.5%, 101/354) (p < 0.001). Upon correction for the sex distribution and analytical differences between the study arms, the diagnostic yield difference between GS and SoC was reduced to 7.3% (p = 0.069). De novo variants were found for 23.6% of patients. Analysis of inherited variants in genes associated with autosomal dominant phenotypes contributed more to the diagnostic yield (3.9%) than X-linked variants (1.9%), and to a similar extent as autosomal recessive variants (4.1%). CONCLUSIONS: This nationwide study indicates GS outperforms SoC for the diagnosis of patients with DD in a decentralized hospital setting and well-characterized cohort. The results also highlight the importance of evaluating autosomal dominant inherited variants in genomics analyses for DD. TRIAL REGISTRATION: ClinicalTrials.gov (NCT07051213, 03-07-2025).
Source: Genome Medicine
Authors: Geysens Mathilde, Souche Erika, Baroni Maria Chiara, Benoit Valérie, Beyltjens Tessi, Bossuyt Wouter, Bours Vincent, Crabbé Marian, Croes Didier, De Smet Matthias, Désir Julie, Devriendt Koenraad, Dheedene Annelies, Dimitrov Boyan Ivanov, Janssens Katrien, Kumps Candy, Lumaka Aimé, Menten Björn, Meuwissen Marije, Monestier Olivier, Mortier Geert, Olsen Catharina, Palmeira Leonor, Peeters Hilde, Pölsler Laura, Revencu Nicole, Roland Dominique, Soblet Julie, Sznajer Yves, Taziaux Sylvie, Van Esch Hilde, Vandeweyer Geert, Vantroys Elise, Vilain Catheline, Wiame Elsa, Van Den Bogaert Kris, Vermeesch Joris Robert
Institutions: Universitair Ziekenhuis Leuven, Institute of Pathology and Genetics, University of Antwerp, Ghent University Hospital, Antwerp University Hospital, Centre Hospitalier Universitaire de Liège, Cliniques Universitaires Saint-Luc, UCLouvain, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, Université Libre de Bruxelles, Queen Fabiola Children's University Hospital
Language: English
Topic: Genomics and Rare Diseases
Subfield: Genetics
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $5,290
OpenAlex ID: W7219642533
